TrialSafety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Trial details
- Registry ID
- NCT05200936
- Phase
- Phase 2
Drug research
MM120
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as DT120; MM-120; lysergide tartrate
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936 | Definium Therapeutics US, Inc. | Phase 2 | Completed | 2023-11-06Actual |
| A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 | Definium Therapeutics US, Inc. | Phase 2 | Completed | 2023-10-06Actual |
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Trial details
- Registry ID
- NCT05407064
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |